US Patent Issued to Juno Therapeutics on March 25 for "Process for generating therapeutic compositions of engineered cells" (Washington, California Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,580, issued on March 25, was assigned to Juno Therapeutics Inc. (Seattle).

"Process for generating therapeutic compositions of engineered cells" was invented by Sarah Y. Lee (Mercer Island, Wash.), Pascal Beauchesne (Seattle), Mark L. Bonyhadi (Sammamish, Wash.), Ryan L. Crisman (Seattle), Ryan P. Larson (Seattle), Mary Mallaney (Seattle), Christopher Glen Ramsborg (Seattle), Clinton Weber (Seattle), John Matthew Wesner (Seattle) and Nathan Yee (Seattle, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. In some aspects, th...